Quotes from the news wire:
We believe fundamentally that people want a choice in the vaccines that they're able to have for themselves, and especially in this population that we're talking about for children, so, we think that that kind of reassuring technology platform that's understood, combined with the high levels of efficacy and the well-tolerated safety profile, can help increase that vaccination number in children.
Found on CNN 2 years ago
We recently initiated a trial that we're calling Hummingbird, which is a Phase 2b/3 trial, and that's going to be an effectiveness and efficacy trial and also clearly be looking at safety, and that will have three age cohorts, the first cohort of kids, that trial was already initiated, and that's for kids 6 to 11.
Found on CNN 2 years ago
Our intent is to file for authorization of a BA.5-containing bivalent form of a vaccine in the fourth quarter of this year, this is consistent with the approach that other manufacturers are following.
Found on CNN 2 years ago
One of the things that we believe makes our vaccine unique is that we actually see really good immune response against variants with our prototype vaccine. And so, if you think about the vaccine that we already have authorized that we're talking about now to be authorized for adolescents, we actually see a good immune response against variants including Omicron, including BA.1 and BA.5.
Found on CNN 2 years ago
Quote of the Day Today's Quote | Archive
Would you like us to send you a FREE inspiring quote delivered to your inbox daily?
Citation
Use the citation below to add this author page to your bibliography:
Style:MLAChicagoAPA
"Silvia Taylor Quotes." Quotes.net. STANDS4 LLC, 2025. Web. 12 Jan. 2025. <https://www.quotes.net/authors/Silvia+Taylor+Quotes>.
Powered by CITE.ME
Share your thoughts on Silvia Taylor's quotes with the community:
Report Comment
We're doing our best to make sure our content is useful, accurate and safe.
If by any chance you spot an inappropriate comment while navigating through our website please use this form to let us know, and we'll take care of it shortly.
Attachment
You need to be logged in to favorite.
Log In